YesIam
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
wow, Another news. I hope this make it green today if company stop to sell and short sell.
Emergent and Proposed Acquisition Partner Regen Biowellness to Re-Launch FDA Registered Patented Immune Booster ImmunaZin(TM) To Significantly Increase Revenues
Press Release | 07/12/2022
HAUPPAUGE, NY / ACCESSWIRE / July 12, 2022 / Emergent Health Corp. ("Emergent") (OTC PINK:EMGE) announces that upon its anticipated acquisition of Regen Biowellness ("Regen") this month, it intends to re-launch Regens FDA Registered Immune Booster supplement ImmunaZin™ to significantly increase Revenues.
ImmunaZin™ is a patented, proprietary blend of 44 amino acid fragments derived from the enzyme pepsin which is market ready for sale. ImmunaZin™ works by increasing the number of T helper cells in the human body. T helper cells enable cells called macrophages to kill disease-causing pathogens and other invaders. This makes ImmunaZin™ strikingly different from most other immune boosters on the market as it is a novel and potent T cell stimulator, enabling the immune system to aggressively defend against invasions of disease-causing pathogens. The plan calls for bringing on one or more "wholesale to retail" and "multi-level-marketing" U.S. and international marketing, sales, and distribution partners with the assistance of a digital marketing campaign.
Jim Morrison, President and CEO of Regen Biowellness stated, "With the anticipated upcoming merger between ReGen and Emergent, we will have over two dozen high quality products that are market ready. Products like ImmunaZin™ are intended to be rebranded, repackaged, and brought to market during this year's fourth quarter. The ultimate goal of the combined Emergent-Regen company is to be a leader in the plant-based wellness category for all channels of distribution."
ABOUT EMERGENT HEALTH CORPORATION
Emergent is developing a line of products in the field of Regenerative Medicine and improved Neutraceuticals and Phytonutritionals available to the general public without a prescription. Its products comprise ingestibles as well as topicals for the whole family. The company intends to distribute its products online and through content based shopping using Influencers to position their products throughout the United States and Internationally. PharmaZu its newly acquired subsidiary, is a pure play, e-commerce products and service provider focused on the pet community, pet pharmacy and pet wellness using Influencers and their content. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease.
Before using any products, you should always consult with your Veterinarian and Family Doctor.
wow, there is a news this morning.
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro
Press Release | 07/08/2022
COCONUT CREEK, FL, July 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – NutraLife Biosciences Inc. (OTC: NLBS), a manufacturer and distributor of private label and branded nutraceutical and skincare products, today announced it has executed a joint venture agreement with Emergent Health Corp. (“Emergent”) (OTC: EMGE) for the co-production, co-marketing, and distribution of Emergent’s line of regenerative, and other health-related nutraceutical products.
Nutralife is a developer, manufacturer, and distributor of various nutraceutical and skincare products with more than 50 different products and formulations. NutraLife products are made with the finest, most effective ingredients, some of which include CBD. These products by design support and cater to a multitude of health and wellness applications to help and improve one’s quality of life. NLBS has operated as a manufacturer of health and wellness consumer goods for approximately 12 years, is SEC fully reporting, and has traded publicly on the OTC Markets for 8 years.
The joint venture to co-produce and co-market Emergents products will support the company’s national reach for Emergents products. Collaborating with Nutralife to utilize their extensive, and established production facilities along with their e-commerce and retail marketing platforms and resources will provide great distribution channel opportunities for launching our products to the consumer marketplace.
Additionally, the facilities and abilities of Nutralife will be used in collaboration with our PharmaZie line for the production and development, and distribution of proprietary pet products allowing us to greatly increase the availability and coverage of our Pharma products.
Edgar Ward, President, and CEO of Nutralife stated, “We are pleased to be working with Emergent and PharmaCy and look forward to a prosperous, impactful relationship. We are mindful of our principles and mission every day as we launch various products that help to improve the daily health and wellness of lives inside and out for ourselves and our pets.
Jim Zimbler, CEO of Emergent, stated, “We are extremely pleased and excited to partner with Edgar Ward and Nutralife for the production and marketing of our Emergent line of products. With the help of Nutralife, we are moving forward with the re-launch of our portfolio of products.”
ABOUT NUTRALIFE BIOSCIENCES, INC.
NutraLife BioSciences, Inc. operates a multifaceted life sciences and lifestyle health and wellness manufacturing company. For more than twelve years, NutraLife has manufactured and distributed both private label and branded nutraceutical and skincare wellness products.
For more information, visit our website at www.nutralifebiosciences.com.
Nice pullback. This means tomorrow is going to be greeeennnnn.
Nice turnaround with reversal.
Reversal started. It might get close in green.
let's ignore. People put stuff without any proof. This will go up soon. It's accumulating.
Selling is Drying up. It will start to shoot up at any time.
Looks like party is getting started. Stay tuned.
KING RESOURCES INC - Huge bid - This time it will cross .0021 before closing
$0.0016
x 14500
+$0.0005 (47.62%)
Refresh Quote
Bid
0.0015 x 3000000
Ask
0.0016 x 350000
Volume
50,447,473
I believe something big is happening behind the scene. We will know in next few days.
How does it related to COSG?
I was chatting with Flord team and here is their response. It looks like tons of details coming by end of this week.
We are finalizing the updates and should be published by the end of the week.
Regarding content, there will be a login portal for current & future retail distribution partners.
There is a ton of additional content that is being made ready and will start dropping at the end of the week and through our debut at our first trade show in Las Vegas.
Additionally, customers will be able to geolocate their closest flörd retailer from the site for their convenience.
flörd team
Huge bid of 102M+ @.001
I can understand that they increased outstanding share. This is nothing new. Most of company does in otc market to eliminate debt. It looks like it might close in green by end of day.
I won't be surprised it it reaches .01 by tomorrow with tiny float.
wow. it crossed 25 now.
Great. Finally. It crossed that mark.
Lunch is over. Time to break .002. Let's get it.
It will break soon. Entire float is in strong hands.
Great. I believe it will start to move up once it reaches .002
KLDO is going to move up at any time now with tiny volume. It went up 55% yesterday. Once it crosses .10 then sky is limit.
Someone bought almost 700K says something is coming.
Wow, it has $ cash 2.4M and $20M invested with low float. I believe it will exceed 52 weeks high tomorrow into Friday.
HMNU has a super low float with just 881,930,000 shares outstanding, 489,246,567 of which are restricted leaving just 392,683,433 free trading shares worth under $2 million at current market levels. HMNU has $2.4 million in the treasury and $20 million in investments vs. a $21.7 million deffered note payable. For the 3 months ended March 31, the Company reported revenues of $358,000 and a net income of $98,860.00 compared to $59,860.00 for the prior quarter. The $39 million in revenues from the Company’s HMNU-MSK Kinesis Medical Equipment will augment current sales very nicely.
This went above .05 last year. With this news, it can go above 10 cents easily.
Agreed. $30M order is not joke. Today is first day. It will continue to go up into memorial weekend.
Very nice day. Only 200K at closing bring down from .0063 to .0053. This is going to go up tomorrow into long weekend.
Float might be little higher. However, it's nothing compared to other stocks in OTC market. This is going fly.
it does not need PR. it went above 5 cents few days back without any news. Sky is the limit is any news issued by company.
Touched .0065. Volume is picking up.
EBML is going to take off. Get in now.
About take off anytime now.
Let's take out 110K @55
Looks like it's moving up now.
Selling pressure is gone. Time to go up now.
Added more this morning. Will add more if sees opportunity.
This is moving like GHML. It can fly at any time.
looks like it want to go above penny. It can happen at any time. If not today then it will be next week.
The way it is trading with small number of shares, it can move up fast.
wow. this has tiny float of 16M only that is locked on longs hand. This will start to go up. Once it crosses 1 cent then will move fast.
What's going on here? It looks like going to test high of last week.